Skip to main content
Journal of Virology logoLink to Journal of Virology
. 1986 Dec;60(3):1153–1155. doi: 10.1128/jvi.60.3.1153-1155.1986

Protection against yellow fever in monkeys by immunization with yellow fever virus nonstructural protein NS1.

J J Schlesinger, M W Brandriss, C B Cropp, T P Monath
PMCID: PMC253373  PMID: 3783816

Abstract

Immunization of monkeys with yellow fever virus-specified nonstructural protein NS1 resulted in protection against fatal hepatitis as well as marked reduction in the magnitude of viremia after subcutaneous challenge with yellow fever virus. The results may be relevant to the design of possible subunit or recombinant flavivirus vaccines.

Full text

PDF
1153

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. CLARKE D. H., CASALS J. Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses. Am J Trop Med Hyg. 1958 Sep;7(5):561–573. doi: 10.4269/ajtmh.1958.7.561. [DOI] [PubMed] [Google Scholar]
  2. Cardiff R. D., Lund J. K. Distribution of dengue-2 antigens by electron immunocytochemistry. Infect Immun. 1976 Jun;13(6):1699–1709. doi: 10.1128/iai.13.6.1699-1709.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Chappell W. A., Sasso D. R., Toole R. F., Monath T. P. Labile serum factor and its effect on arbovirus neutralization. Appl Microbiol. 1971 Jan;21(1):79–83. doi: 10.1128/am.21.1.79-83.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Earley E., Peralta P. H., Johnson K. M. A plaque neutralization method for arboviruses. Proc Soc Exp Biol Med. 1967 Jul;125(3):741–747. doi: 10.3181/00379727-125-32194. [DOI] [PubMed] [Google Scholar]
  5. Gould E. A., Buckley A., Barrett A. D., Cammack N. Neutralizing (54K) and non-neutralizing (54K and 48K) monoclonal antibodies against structural and non-structural yellow fever virus proteins confer immunity in mice. J Gen Virol. 1986 Mar;67(Pt 3):591–595. doi: 10.1099/0022-1317-67-3-591. [DOI] [PubMed] [Google Scholar]
  6. Rice C. M., Lenches E. M., Eddy S. R., Shin S. J., Sheets R. L., Strauss J. H. Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution. Science. 1985 Aug 23;229(4715):726–733. doi: 10.1126/science.4023707. [DOI] [PubMed] [Google Scholar]
  7. Schlesinger J. J., Brandriss M. W., Monath T. P. Monoclonal antibodies distinguish between wild and vaccine strains of yellow fever virus by neutralization, hemagglutination inhibition, and immune precipitation of the virus envelope protein. Virology. 1983 Feb;125(1):8–17. doi: 10.1016/0042-6822(83)90059-4. [DOI] [PubMed] [Google Scholar]
  8. Schlesinger J. J., Brandriss M. W., Walsh E. E. Protection against 17D yellow fever encephalitis in mice by passive transfer of monoclonal antibodies to the nonstructural glycoprotein gp48 and by active immunization with gp48. J Immunol. 1985 Oct;135(4):2805–2809. [PubMed] [Google Scholar]
  9. Smith G. W., Wright P. J. Synthesis of proteins and glycoproteins in dengue type 2 virus-infected vero and Aedes albopictus cells. J Gen Virol. 1985 Mar;66(Pt 3):559–571. doi: 10.1099/0022-1317-66-3-559. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES